Pharmaceutical companies seeking tie-ups over development of anti-obesity drugs

Now that the prevalence of obesity has been increasing at an alarming rate over the past few years, not only in the industrialized nations, but also in the developing ones, the focus of government agencies and pharmaceutical companies is on establishing preventive programs and developing anti-obesity agents.

In a recent report, Frost & Sullivan’ Korean Unit says that although there have been...